Q: How does BPC-157 compare to injected PRP
Rushing through the titration schedule often means more severe GI symptoms, worse adherence, and sometimes temporary discontinuation, which ultimately slows progress
If you experience severe abdominal pain, persistent vomiting, or signs of gastroparesis (severely delayed stomach emptying with nausea and inability to eat), your dose may need adjustment or your medication may need to be paused temporarily
Smart use rules Keep sessions simple and spaced
A phase 2 trial published in the New England Journal of Medicine showed average weight loss of over 24% at 48 weeks, and the first phase 3 results in December 2025 suggested that average weight loss could be around 28 to 29%
Our approach is holistic and tailored to each individual